Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion
Evaluating the Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion in Hip Fracture Patients
Sponsor: Gregory M Georgiadis MD
A PHASE4 clinical study on Hip Fractures, this trial is actively recruiting participants. The trial is conducted by Gregory M Georgiadis MD and has accumulated 12 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE4
-
Oct 2024 — Sep 2025 [monthly]
Recruiting PHASE4
Status: Unknown → Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Nov 2021 — Oct 2023 [monthly]
Recruiting PHASE4
-
Jan 2021 — Nov 2021 [monthly]
Recruiting PHASE4
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Apr 2019 — Jul 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gregory M Georgiadis MD
For direct contact, visit the study record on ClinicalTrials.gov .